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Abstract
The endosomal sorting complex required for transport (ESCRT) organises in supramolecular 
structures on the surface of lipid bilayers to drive membrane invagination and scission of 
intraluminal vesicles (ILVs), a process also controlled by membrane mechanics. However, 
ESCRT association with the membrane is also mediated by electrostatic interactions with 
anionic phospholipids. Phospholipid distribution within natural biomembranes is 
inhomogeneous due to, for example, the formation of lipid rafts and curvature-driven lipid 
sorting. Here, we have used phase-separated giant unilamellar vesicles (GUVs) to 
investigate the link between phosphatidylserine (PS)-rich lipid domains and ESCRT activity. 
We employ GUVs composed of phase separating lipid mixtures, where unsaturated DOPS 
and saturated DPPS lipids are incorporated individually or simultaneously to enhance PS 
localisation in liquid disordered (Ld) and/or liquid ordered (Lo) domains, respectively. PS 
partitioning between the coexisting phases is confirmed by a fluorescent Annexin V probe. 
Ultimately, we find that ILV generation promoted by ESCRTs is significantly enhanced when 
PS lipids localise within Ld domains. However, the ILVs that form are rich in Lo lipids. We 
interpret this surprising observation as preferential recruitment of the Lo phase beneath the 
ESCRT complex due to its increased rigidity, where the Ld phase is favoured in the neck of 
the resultant buds to facilitate the high membrane curvature in these regions of the 
membrane during the ILV formation process. Ld domains offer lower resistance to membrane 
bending, demonstrating a mechanism by which the composition and mechanics of 
membranes can be coupled to regulate the location and efficiency of ESCRT activity.
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Introduction
The precise molecular composition of lipid membranes determines the physicochemical 
properties that regulate biological cell homeostasis1, such as membrane fluidity and phase 
behaviour. Lipid membrane fluidity and phase behaviour influences the mechanical 
properties of membranes (e.g., bending modulus2, spontaneous curvature3) and phase 
separation imparts spatial ordering of lipids, which can play a role in biological signalling (in 
so-called lipid rafts).4,5 This spatial ordering of lipids modulates the local mechanical 
properties of membranes2,6 which plays a key role in signalling mechanisms comprising of 
membrane fusion and fission events.4,5,7 
Membrane tension regulates the activity of membrane-remodelling protein complexes such 
as dynamin8 and the Endosomal Sorting Complex Required for Transport (ESCRT), which 
drives membrane budding and scission in multivesicular body biogenesis, viral budding, 
repair of plasma, nuclear and organelle membranes.911 The core scission machinery of 
ESCRT is comprised of the ESCRT-III complex and the adaptor complex ESCRT-II, which 
binds specifically to phosphatidylinositoside phosphates (PIPs) and ESCRT-III initiates 
membrane invagination.12 In budding yeast, ESCRT-III assembles from four key subunits 
(Vps20, Snf7, Vps24 and Vps2) and the AAA+ ATPase Vps4 that regulates the formation of 
ESCRT-III three-dimensional spiral structures.13 These structures are capable of stabilising 
membrane buds and constricting membrane necks in an ATP-dependent manner.13 
The budding and scission activity of the ESCRT-II and ESCRT-III complexes can be 
reconstituted in vitro by following the generation of intralumenal vesicles (ILVs) within giant 
unilamellar vesicles (GUVs) after the addition of purified ESCRT components.12,14 In this 
bulk-phase encapsulation assay, only ESCRT-generated ILV compartments contain 
fluorescent extravesicular medium in their lumens allowing the quantification of ESCRT-
mediated membrane-remodelling upon a change in experimental conditions. In vitro systems 
to study how bulk phase is encapsulated into membrane compartment by protein complexes 
such as ESCRT also represent a useful biomimetic tool to create multi-compartment 
architectures incorporating spatially segregated, chemically distinct environments and 
possess significant promise in the construction of complex artificial cells.15,16
It is well established that specific lipid headgroups play key roles in signalling and protein 
recruitment processes.17 Anionic PIPs and phosphatidylserine (PS) lipids are necessary to 
initiate ESCRT activity at the membrane.18 Specifically, PS lipids are necessary for the 
binding of ESCRT-III subunits prior to complex assembly and membrane remodelling9,1921 
whereas ESCRT-II subunits specifically binds PI(3)P22 though phosphoinositides are not 
strictly required for scission activity.14
The affinity of ESCRTs for specific lipids therefore provides an opportunity to employ phase 
separated model membranes to investigate how spatially distinct lipid distribution between 
membrane phases of differing fluidity and mechanics influences their function and activity in 
vitro. Simple mixtures of saturated lipids, unsaturated lipids and cholesterol can be designed 
to phase separate into coexisting fluid membrane phases that are thought to mimic the 
structural properties of native lipid rafts.2326 The liquid disordered (Ld) phase is enriched in 
unsaturated lipids and is characterised by higher fluidity and lower bending rigidity, while 
cholesterol and saturated lipids concentrate in more viscous and rigid liquid ordered (Lo) 
domains. Equilibration of phase separating GUV membranes results in membrane textures 
that coarsen into large microscale domains that minimise the interfacial tension between 
coexisting phases. These domains can easily be visualised by fluorescence microscopy 
techniques due to preferential partitioning of lipophilic trace fluorophores between distinct 
membrane phases.27,28
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Here we show that ESCRT-II/ESCRT-III activity is increased in PS-rich Ld microdomains with 
the newly formed ILVs containing predominantly Lo phase membranes. Given the 
relationship between mechanical properties and membrane phases, our data suggests 
further insight into the mechanism of mechanical deformation of membranes by the ESCRT 
complex. Furthermore, if specific lipids can indeed be used to target ESCRT-driven ILV 
formation to membrane microdomains then we can envisage strategies for generating ILVs 
with physicochemical properties selectively distinct from their parent membrane.
Our data provides further insight into the in vitro mechanism of mechanical deformation of 
membranes by the ESCRT complex and might aid the understanding of ESCRT-related 
events at biological membranes. 
Results and discussion
Strategy
We and others14,15,29 have successfully used GUVs composed of homogeneous 
PC:Cholesterol:PS mixtures to reconstitute the membrane remodelling activity of the 
ESCRT-II/ESCRT-III complex. Based on phase diagrams available in the literature for 
DOPC:DPPC:chol mixtures,30 we selected a baseline membrane composition of 35:35:30 as 
it is fairly central within the liquid ordered (Lo) - liquid disordered (Ld) coexistence region of 
the phase diagram. 13 mol% of PC lipids were exchanged for the corresponding PS lipid 
with the same acyl tails (e.g.: DOPC for DOPS) in each formulation, with either 13 mol% 
DOPS, 13 mol% DPPS or 6.5 mol% DOPS + 6.5 mol% DPPS. Figure 1 depicts the 
expected distribution of PS lipids in our formulations due to preferential partitioning of these 
lipids between the coexisting phases and the hypothesised resulting ILV membrane 
compositions. 
Figure 1: Schematic of hypothesised outcomes from ESCRT-driven ILV formation activity against GUVs with 
differently distributed PS-headgroup lipids. ILV membrane composition may reflect the relative distribution of the 
phase(s) with increased PS concentration. Red: Ld membrane, Blue: Lo membrane. 
Controlling the phase distribution of PS-headgroup lipids
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Figure 2: Confocal microscopy of phase separated GUVs. (A) 28.5 : 28.5 : 13 : 30 DPPC : DOPC :DOPS : Chol, 
(B) 28.5 : 28.5 : 13 : 30 DPPC : DOPC :DPPS : Chol, (C) 28.5 : 28.5 : 6.5 : 6.5 : 30 DPPC : DOPC :DOPS : 
DPPS : Chol. Rh-PE preferentially partitions into Ld domains, Napthopyrene (Np) preferentially partitions into Lo 
domains, AF488-AxV selectively binds to PS lipids to indicate distribution with respect to the domains of different 
membrane phases. 
Confocal microscopy of GUVs treated with the PS-binding protein Annexin V, fluorescently 
labelled with AlexaFluor488 (AF-488-AxV), was used to assess PS localisation in each 
formulation with respect to membrane phase domain (Figure 2). Phase character was 
indicated by the partitioning of Naphtho[2,3-a]pyrene (Np) into Lo domains and of 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine-N-(Lissamine rhodamine B sulfonyl) ammonium 
salt, (Rh-PE) into Ld domains.27 The great majority of GUVs were observed to have roughly 
hemispherical Lo/Ld distributions, although some striped and spotted domains were also 
sporadically observed The expected phase-enriched distributions of PS lipids were obtained 
reliably, (Lo PS enrichment with DPPS, Ld enrichment with DOPS, and comparable 
distributions in the 6.5 mol% DPPS, 6.5 mol% DOPS 1:1 mixture. The distribution of AF-
488-AxV within enriched phases was highly uniform other than some isolated cases where 
enhanced AF-488-AxV fluorescence was observed along phase boundaries in the 1:1 PS 
composition, but this was rare.
PS in the Ld phase enhances efficiency of ILV formation
ESCRT activity was assessed by ILV counting. Membrane-impermeable fluorescent dyes 
were added to GUV suspensions, followed by ESCRT proteins (50 nM Snf7, 10 nM each of 
ESCRT-II, Vps20, Vps24, Vps2 and Vps4, and 10 K ATP.MgCl2), all added simultaneously. 
The presence of fluorescent dye in the lumens of free-floating ILVs, after incubation with 
ESCRT proteins, being a strong indication that those ILVs were formed as a result of 
ESCRT activity.15 The number of dye-containing ILVs was counted and then expressed as a 
number of ILVs per GUV volume equivalent, by taking the luminal volume observed during 
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large area tile-scan imaging of GUV samples (cross sectional area x section thickness), 
divided by the volume of a typical 20 m diameter GUV Figure 3. Automation of ILV 
counting was made possible by using the calcein-Co2+ fluorescent dye-quencher pair in this 
assay, as fluorescence in the bulk medium could be quenched after the ESCRT incubation 
period by addition of the membrane-impermeable quencher (CoCl2). This means that only 
ILVs containing calcein fluorescence had formed during the period of incubation with 
ESCRTs. 
Figure 3: The impact of PS phase localisation on the ILV-forming activity of ESCRTs. The graph shows the 
number of ILVs per GUV volume equivalent for GUVs incubated with the ESCRT-II/III complex (Snf7 50 nM, 
ESCRT-II, Vps20, Vps24, Vps2, Vps4 (10 nM) and ATP.MgCl2 1 M. ILVs are determined to be formed post-
ESCRT addition by the presence of calcein fluorescence. GUVs either contained DOPS localised to the Ld 
domains, DPPS localised to the Lo domains, or a 1:1 mix of DOPS and DPPS that fairly evenly distributed 
between the coexisting phases. Diagram: Red: Ld membrane, Blue: Lo membrane. 
The results, shown in Figure 3, indicate that the relative localisation of PS-headgroup lipids 
in phase-separated GUVs has a significant influence on the extent of ESCRT-induced ILV 
formation. The highest ILV formation activity was seen within GUVs containing 13 mol% 
DOPS, where PS lipids are predominantly located in the Ld phase domains of the GUVs. In 
contrast, the lowest ILV formation activity was seen in GUVs where PS is preferentially 
located in the Lo-phase (13 mol% DPPS GUVs). Finally, where PS is found in both phases 
(1:1) an intermediate degree of ILV formation was observed.
This suggests that the concentration of PS lipids in Ld domains also regulates the degree of 
ESCRT activity. We can rationalise these findings by taking into consideration the lower 
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bending rigidity of each phase; the lower bending rigidity of an Ld phase, offers lower 
mechanical resistance to ESCRT-induced membrane deformation than a Lo domain.2,31 
ESCRT activity is negatively regulated by membrane tension, in a manner that is likely 
analogous to suppression of activity by higher bending rigidity.15 We conclude that ESCRT 
activity must be higher at PS-containing Ld domains where the membrane is more 
susceptible to deformation.
ESCRT-induced ILVs consist of Lo phase membranes
Surprisingly, the ILVs that form mostly consist of Lo membranes, despite localisation of PS 
lipids in Ld domains (Figure 4, blue bars). This is determined by the observed depletion of 
the Ld-partitioning Rh-PE probe from the membranes of ILVs, indicating a lack of liquid 
disordered phase membrane. In contrast with the few ILVs present in the GUV lumen prior to 
addition of proteins, lacking encapsulated calcein, and formed as a random by-product of the 
electroformation process, (Figure 4, red bars), showed greater Ld compared to those formed 
by ESCRT activity.
We therefore quantify the relative phase character of ILVs formed by ESCRTs and those 
that occur intrinsically to ascertain the significance of this observation. We quantified the 
area mean fluorescence intensity of the Rh-PE for each individual ILV present before and 
after the addition of ESCRT proteins, taking this as a measure of the proportion of the Ld 
phase in the volume of the ILV (Figure 4). Analysis of Rh-PE fluorescence is more robust 
than analysis of the Np fluorescence, due to the weaker overall fluorescence and its minor 
overlap with the fluorescence emission of encapsulated calcein.  
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Figure 4: ILV membranes are predominantly Lo phase. Histograms of mean Rhodamine-PE fluorescence 
intensity in ILVs, a measure of the phase character of the membranes. Red plots: Intrinsic ILVs (ESCRT-
independent). Blue plots: ESCRT-induced ILVs. a) 13 mol% DOPS GUVs, b) 6.5 mol% DOPS, 6.5 mol% DPPS 
GUVs, c) 13 mol% DPPS GUVs, d) overlaid post-ESCRT ILV data for each composition (green = DOPS, grey = 
1:1 mixture, yellow = DPPS). Diagrams: Red: Ld membrane, Blue: Lo membrane.
The 13 % DOPS (Figure 4.a) and 1:1 DOPS:DPPS (Figure 4.b) GUV samples, show a 
distinctly lower mean Rh-PE fluorescence than intrinsic ILVs, We interpret this as a decrease 
in Ld character of the membrane, or alternatively, a significant enrichment of Lo phase in 
ESCRT-induced ILVs.
This observation was surprising since it would be reasonable to anticipate that the ILVs form 
from the PS-enriched phase of the parent GUV membrane and hence have a similar 
composition and phase character. However, this result is consistent with previous 
suggestions of localisation of ESCRT complexes at phase boundaries, where local 
membrane curvature may help to nucleate the assembly of ESCRT-III.18
The GUVs containing 13 mol% DPPS exhibit ILVs with a very broad range of mean 
fluorescence intensities with no obvious compositional preference (Figure 4. C). This lack of 
selectivity for Lo or Ld domains and significantly reduced ILV formation activity (Figure 3) 
suggests ESCRT activity is dysregulated when PS is enriched in the Lo domains, the tighter 
packing of lipids in this phase may inhibit membrane insertion of the amphipathic helix of 
Snf7, thereby restricting its normal assembly and function.32,33 
Figure 5: Representative images of observed phase characteristics in GUVs incubated with ESCRTs. A: High 
yields of ESCRT-induced ILVs in an individual GUV causes depletion of Ld phase from the parent membrane. 
Confocal microscopy of GUVs (13 mol% DOPS) after incubation with ESCRT proteins and quenching of 
background calcein fluorescence with CoCl2. Left: Rh-PE, Centre: calcein, Right: merge. B: Confocal microscopy 
images of GUVs with apparent stalled ILV buds. i and ii are distinct GUVs, iii is an enlargement of the yellow box 
in I, left to right; Rh-PE, Np, fluorescein labelled dextran, 70 kDa, both GUVs are 1:1 composition (6.5 mol% 
each of DPPS and DOPS. A(i) is an enlargement of the area designated by the yellow square on A Green: 
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fluorescein labelled dextran (70 kDa), Red: Rhodamine-PE, Blue: Np. C: Schematic interpretation of ILV bud 
phase character distribution based on images 5.B (i) and (ii). D: Lo GUV with calcein containing ILVs with 
adherent Ld GUV, possibly a result of ESCRT-induced abscission.
A representative image of DOPS-containing GUVs after incubation with ESCRTs is shown in 
Figure 5 A. Here, the significant reduction in Rh-PE fluorescence in ESCRT-induced (those 
containing green calcein fluorescence) relative to intrinsic ILVs is strikingly illustrated. 
However, Figure 5 A also illustrates a common observation in GUV samples with 
compositions containing DOPS (13 mol% DOPS, 1:1 DOPS:DPPS), that GUVs with a high 
abundance of ESCRT-induced ILVs tend to have a predominantly Lo parent membrane. This 
is a highly counterintuitive finding as the expectation would be that any mechanism that 
favours the formation of Lo ILVs necessarily leads to the removal of Lo lipids from the parent 
GUV membrane. Having already shown that PS-localisation in the Lo phase inhibits ESCRT 
activity, it is unlikely that ESCRTs have preference for Lo-only vesicles in the DOPS GUV 
samples. Indeed Lo-only GUVs were not observed prior to ESCRT addition, suggesting that 
such vesicles are ESCRT-induced and high ILV formation activity in a single vesicle likely 
results in shedding of Ld phase from the parent membrane. We will show evidence for this in 
rare observations of stalled ESCRT-induced membrane buds.
Stalled ILV buds reveal insights into the mechanism of Lo-enrichment in ILVs
We observed that a small number of GUVs with a 1:1 DOPS:DPPS composition contained 
stalled ILV buds (Figure 5 B).  One mechanism by which these stalled ILV buds may appear 
is when the membrane tension of a particular GUV is sufficient to allow initial invagination of 
the ILV bud, but mechanical resistance stalls ILV formation prior to scission of the bud neck. 
We have previously observed a number of these stalled buds in homogeneous GUV 
membranes interacting with ESCRT proteins.15 Alternatively, rare assembly errors in the 
formation of these complexes may have resulted in incompetent ESCRT machinery that is 
unable to complete the final neck closure and scission steps.
These nascent buds are yet to be closed off from the extravesicular medium given that we 
observe a continuity of fluorescein-labelled dextran ([70 kDa]) from the bulk phase into the 
bud volume. These buds have a neck of approximately 2 m diameter, which correlates with 
the typical size range of ILVs observed in these experiments (~1-2 m diameter). The 
membrane phases show an unusual distribution in these bud structures where buds occur at 
or near to a phase boundary, with the portion of the membrane that buds into the parent 
GUV lumen being predominantly Lo (Figure 5 B i). However, there is an accumulation of Ld 
membrane on the exterior of the parent membrane adjacent to the bud neck, which could be 
interpreted as a collar of Ld membrane (see Figure 5 C). This contrasts somewhat with the 
structure observed in Figure 5 B ii, where again, a Lo bud is observed at a phase boundary, 
with Ld accumulation around the bud neck, but there is also a protrusion of Ld material into 
the bud lumen. Despite the infrequent observation of this phenomenon, there is a clear 
correlation with the prevalence of Lo phase character in ESCRT-induced ILVs as shown in 
Figure 4. 
Proposed mechanism of Lo-enriched ILV formation
ILV formation is most efficient when PS lipids are localised within Ld domains of phase 
separated GUVs. Electrostatic association of the ESCRT-III proteins with PS lipids would be 
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expected to concentrate initial binding onto Ld domains. Curvature generated at phase 
boundaries34 may also preferentially nucleate ESCRT-III assembly at these sites.18 
Assembly of ESCRT complexes on the membrane likely increases the local membrane 
rigidity, suppressing thermal undulations. Suppression of membrane undulations in adhesion 
plaques has previously been shown to promote formation and localisation of more rigid 
membrane phases,35  and similar observations have recently been reported in vivo.36 
Moreover, induced formation of Lo membrane beneath ESCRT-II assemblies has previously 
been reported on solid-supported lipid bilayers.37 
Induced recruitment of Lo membrane beneath an ESCRT-II complex will create a line tension 
with the Ld phase at the domain boundaries. The energy cost of this phase boundary can be 
minimised by bending the membrane such that the circumference of the phase boundary 
decreases, promoting budding of the Lo domain.38 The Ld phase at the Lo domain boundaries 
is likely required to facilitate the high curvature in the bud neck, while the line tension within 
the Ld-Lo phase boundary within the bud neck could enhance the efficiency of scission of the 
bud from the parent membrane, forming the ILV.3941 It should be noted that the curvature of 
the Lo domain bud (radius of curvature ~ 1 K4 is much lower than in the bud neck (radius of 
curvature ~ 10s nm). These ESCRT-induced Lo buds may preferentially migrate to the 
macroscopic phase boundaries within the GUV, or preferentially nucleate in these regions of 
the vesicle, as observed in Figure 5 B i, ii. Figure 5B also shows strong evidence for 
involvement of Ld phase lipids in the neck of Lo-rich membrane buds.
Notably, there is evidence for lipid sorting during vesicle budding processes in vivo, in the 
generation of endosomes, multivesicular bodies and exosomes.42 Interestingly, many 
lipidomics studies have reported enrichment of sphingomelin and cholesterol in endosomes 
and exosomes relative to their parent membrane (the plasma membrane), suggestive of a 
greater Lo phase character.4346 Furthermore, a recent detailed lipidomics analysis of 
membranes in erythrocytes reveals that PS lipids with highly unsaturated acyl chains tend to 
concentrate at  the cytoplasmic-facing leaflet of the plasma membrane, thus implying they 
might preferentially localise within Ld regions of membranes where ESCRT activity is also 
engaged.47 The parallels with the Lo-enrichment in phase separated GUV model membranes 
reported here are striking.
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Figure 6: Proposed mechanistic models of the phase behaviour observed in ESCRT-induced ILV formation in 
phase separated GUVs. A: Model of ESCRT assembly and membrane remodelling activity in GUVs with PS 
lipids concentrated in Ld (13 mol% DOPS) or Lo (13 mol% DPPS) domains. B: Depletion of GUV membrane Ld 
domain by ejection of clustered Ld vesicles from the ILV bud neck during scission. C: Possible ESCRT-driven 
scission at GUV phase boundaries leading to distinct enriched or single domain GUVs as observed.
Importantly, ILV formation is strongly suppressed when PS lipids are enriched in Lo domains 
(Figure 3). Therefore, we propose that ESCRT-II/ESCRT-III, preferentially recruited to these 
Lo domains through electrostatic association with DPPS, have suppressed functional activity 
at these membrane domains. This conclusion is supported by the following considerations. 
In the in vivo system, the anchoring of ESCRT-III via membrane-inserting motifs (myristoyl 
moiety in Vps2048 or the N-terminal amphipathic helix in Snf733) may be inhibited in the Lo 
phase, due to more ordered lipid packing and lower incidence of packing defects, resulting in 
lower surface concentration of bound protein.49  Furthermore, the high membrane curvature 
required in the neck of nascent buds would have a much higher energy cost for Lo phase 
membrane than Ld phase membrane, where the energy required to bend the membrane is a 
factor of ~5-6 greater.50  ESCRT assembly on the higher rigidity Lo membrane would also not 
favour recruitment of a different membrane phase beneath the complex, where line tension 
would no longer be generated to favour budding and scission as described above. These 
factors likely combine to strongly suppress ILV formation generated from ESCRT binding to 
Lo domains, where the few ILVs that do form are highly dysregulated in membrane 
composition as observed in Figure 4 C,D.
The observed depletion of Ld lipids from GUV membranes induced by ESCRT-driven ILV 
formation is harder to conclusively explain due to limited experimental evidence. We present 
hypotheses in Figure 6 B, C. In Figure 6 B some of the dense Ld phase membrane 
accumulation around ILV bud necks (as seen in Figure 5B) is detached from the parent 
GUV membrane during the bud scission process. Following numerous ILV formation events, 
the Ld phase may be progressively depleted. Another source for Lo-rich GUVs may be 
ESCRT-driven abscission of entire Ld domains from GUVs, generating separate Ld-rich 
vesicles next to the Lo-rich vesicle as depicted in Figure 6C. This is analogous to the role of 
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ESCRT in cytokinetic abscission.51 A small number of GUVs were observed in this 
configuration in samples incubated with ESCRTs, a representative example is shown in 
Figure 5 D, but we currently have insufficient data to make any strong claims on the 
prevalence of this speculative mechanism. However, shedding of some membrane from 
GUVs caused by ESCRT activity should not be seen as too surprising since excess 
membrane shedding is required for the fission mechanisms at the basis of ESCRT activity in 
vivo.52,53 
Conclusions 
We have shown that ESCRT-driven membrane remodelling in phase separated model 
membranes is most efficient when PS lipids are preferentially located in the less rigid Ld 
domains. At first sight this result is intuitive since these domains offer lower mechanically 
resistance to the budding deformations required for ILV formation. However, surprisingly the 
ILVs that form are strongly enriched in Lo membrane. Combining rare observations of stalled 
ILV formation events and membrane biophysical concepts, we propose a mechanism by 
which this Lo phase enrichment occurs. Generation of ILV proto-organelles with a different 
membrane composition to the GUV parent membrane may have a useful role in generating 
artificial cells that mimic the variability of lipid composition between organelles and the 
plasma membrane of natural cells. Furthermore, the comparison of our observations with the 
enrichment of Lo-preferring lipids in endosomes and exosomes is compelling, suggestive of 
a similar phase-enrichment potentially occurring for ESCRT-generated ILVs in vivo.
Materials and methods
Materials 
All lipids; DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine), DOPS (1,2-dioleoyl-sn-glycero-
3-phospho-L-serine (sodium salt)), DPPC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine), 
DPPS (1,2-dipalmitoyl-sn-glycero-3-phospho-L-serine (sodium salt)), Cholesterol (ovine) and 
Rh-PE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) 
(ammonium salt)) were obtained from Avanti Polar Lipids Inc. (Alabaster, AL, USA). Np 
(Naphtho[2,3-a]pyrene) was obtained from Tokyo Chemical Industries UK Ltd. Calcein, 
NaCl, Tris buffer, CoCl2 (hexahydrate), MgCl2, sucrose, ATP (Adenosine @P8%% 
disodium salt hydrate) were all obtained from Sigma-Aldrich Company Ltd. (UK). 8-chamber 
glass-bottomed microscope slides (Cat. No.  80827) were used for all confocal microscopy 
and were obtained from ibidi GmbH. Annexin V AF488 conjugate (Cat. No. A13201) was 
obtained from Thermo Fisher Scientific Inc.  All proteins were expressed and purified in-
house.
Protein expression
The plasmids for overexpression of Saccharomyces cerevisiae ESCRT-II (Vps22, Vps25, 
Vps36) and ESCRT-III subunits Vps20, Snf7, Vps2 and Vps4 are a gift from James Hurley 
(addgene plasmids #17633, #21490, #21492, #21494, #21495).14,54 The Saccharomyces 
cerevisiae Vps24 gene was subcloned into a pRSET(A) expression vector, containing a 
His6-tag and Enterokinase protease cleavage site. We have previously reported the detailed 
expression and purification methods for the ESCRT-II and ESCRT-III proteins used in this 
the study, including characterisation and quality control data in reference.15
Page 11 of 15 Faraday Discussions
)D
UDG
D\
'LV
FX
VV
LRQ
V$
FF
HS
WHG
0D
QX
VF
ULS
W
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
4 
Ju
ly
 2
02
0.
 D
ow
nl
oa
de
d 
on
 8
/3
/2
02
0 
1:
17
:2
2 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
DOI: 10.1039/D0FD00042F
Electroformation of GUVs
Giant unilamellar vesicles (GUVs) were prepared using the electroformation method. Briefly, 
the desired lipid mixture is applied to indium tin-oxide coated glass slides (8-12 R<2 Sigma-
Aldrich), as a chloroform solution (15 L, 0.7 mM) and dried under nitrogen to form a thin 
film. Lipid compositions were either: 13 mol% DOPS: 35 : 22 : 13 : 30 DPPC : DOPC 
:DOPS : Chol, 13 mol% DPPS: 22: 35 : 13 : 30 DPPC : DOPC :DPPS : Chol, or 1:1  28.5 
: 28.5 : 6.5 : 6.5 : 30 DPPC : DOPC :DOPS : DPPS : Chol. An additional 0.5 mol% of Rh-PE 
and 1 mol% of Np were added to each stock solution. 
Two slides, coated with the desired lipid mixture, were assembled into an electroformation 
chamber by separation of their conductive, lipid-coated surfaces by a silicone rubber gasket 
(~2 mm thickness). Electrical contacts were made to each slide using copper tape and these 
were connected to a function generator. The chamber was then filled with sucrose solution 
(300 mM) and sealed with a silicone rubber plug. The chambers were then placed into an 
oven at 60 °C. An AC field was applied to the chambers; 0.1 Vpeak-to-peak, 10 Hz, sinusoidal 
waveform, ascending to 3 Vpp over 10 min, and maintained at 3 V for 2 h, after which the 
frequency of the oscillation was reduced from 10 to 0.1 Hz over 10 min. At this point the 
GUV-containing sucrose solution was harvested using a syringe. 
Osmotic relaxation of membrane tension was then performed. GUVs were diluted 1:4, 
vol:vol, GUV suspension:hypertonic buffer, with 10 mM Tris buffered saline (~150 mM NaCl; 
pH 7.4), adjusted to 10 mOsm kg-1 higher osmolarity than the sucrose solution and stored 
overnight at 4 °C prior to use. Solution osmolarity was measured using an Advanced 
Instruments 3320 osmometer.
Confocal microscopy
All experiments were performed on Zeiss LSM 700 or 880 systems, imaging with a Plan-
Apochromat 40x/1.4 Oil DIC M27 objective lens, NA = 1.4, 405 nm, 488 nm, and 561 nm 
lasers. GUV suspensions were placed in chamber slides (µslide, 8 well, glass bottomed, ibidi 
GmbH). Glass surfaces in the chamber slides were passivated prior to use by addition of 5 
wt% bovine serum albumin solution in deionised water, incubation for 5 min, followed by 
copious rinsing with milliQ water and finally blown dry using a stream of nitrogen gas. 200 L 
aliquots of GUV suspension were added to each well. 
Annexin V PS localisation assay
Prior to ESCRT assays, separate aliquots of GUVs from the same samples were treated 
with Annexin V, to confirm PS distribution was as expected. AlexaFluor488-labelled Annexin 
V (Thermo Fisher cat. No.: A13201) (2 L per 200 L GUV suspension) was added to 
desired wells and incubated for ~5 min before imaging.
ESCRT-induced ILV counting assay
Calcein (2 L of a 4 mM stock solution in osmotically balanced saline buffer [10 mM Tris, pH 
7.4]) was added to each well (200 L GUV suspension), immediately followed by ESCRT 
proteins; ESCRT-II (Vps22, Vps25, Vps36), Vps20, Snf7, Vps24, Vps2 and Vps4 and 
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ATP.MgCl2 were added to each desired GUV suspension (200 L) to give a final 
concentration of 10 nM for ESCRT-II, Vps20, Vps24, Vps2, Vps4, 50 nM for Snf7, and 10 
M ATP.MgCl2. After a 20 min incubation period, CoCl2 (2 L of a 4 mM stock solution in 
osmotically balanced saline buffer [10 mM Tris, pH 7.4]), was added to quench calcein 
fluorescence in the extravesicular solution. Alternatively, fluorescently labelled dextrans of 
varying molecular weights were added to assess uptake of larger species into ILV lumens. 
All imaging was performed with a pinhole setting that corresponded to a 3.1 m section 
thickness, allowing for a greater volume of a GUVs lumen to be captured and to increase 
the likelihood of ILVs being entirely captured within the visible z-dimension, to improve the 
accuracy of membrane phase characterisation of both ILVs and GUVs. Large area tile-
scanning was performed in order to capture sections through as high a number of GUVs as 
possible, to allow statistical analysis across the GUV population. Images were analysed 
using the Zeiss Zen software and Fiji. To improve comparability between results, ILV counts 
were expressed as ILVs per GUV volume equivalent, being the total GUV lumen observed 
(cross-sectional area x section thickness), divided into units of typical 20 m diameter 
spherical GUV volumes.
ILV phase character analysis
The phase character of ESCRT-induced ILVs was assessed by calculating the mean 
fluorescence intensity of Rh-PE, over the area of the ILV-cross section, as a measure of the 
amount of Ld membrane present. ESCRT-induced ILVs were identified as those which had 
calcein fluorescence in their lumen. This was compared to the same analysis of intrinsic ILVs 
occurring in GUV samples prior to the addition of ESCRT proteins (generated during 
electroformation of GUVs). These naturally occurring ILVs were used as a benchmark for 
the typical average membrane composition of the parent GUV. Therefore a higher Rh-PE 
fluorescence than this benchmark would indicate ESCRT-induced ILVs are enriched in Ld 
phase and a lower average Rh-PE fluorescence would indicate that ESCRT-induced ILVs 
are enriched in Lo phase.
Acknowledgements
This work was funded by the UK Engineering and Physical Sciences Research Council 
(EPSRC): EP/M027929/1 (PAB) and EP/M027821/1 (BC). We also thank Dr. Daniel Mitchell 
for expression and purification of the Vps4 subunit.
References
1 G. van Meer, D. R. Voelker and G. W. Feigenson, Nat Rev Mol Cell Biol, 2008, 9, 112124.
2 H. P. Duwe and E. Sackmann, Physica A: Statistical Mechanics and its Applications, 1990, 163, 410
428.
3 H. T. McMahon and E. Boucrot, J Cell Sci, 2015, 128, 10651070.
4 M. A. Alonso and J. Millán, Journal of Cell Science, 2001, 114, 39573965.
5 P. Varshney, V. Yadav and N. Saini, Immunology, 2016, 149, 1324.
6 W. Shinoda, Biochimica et Biophysica Acta (BBA) - Biomembranes, 2016, 1858, 22542265.
7 S.-T. Yang, A. J. B. Kreutzberger, V. Kiessling, B. K. Ganser-Pornillos, J. M. White and L. K. Tamm, Sci. 
Adv., 2017, 3, e1700338.
8 A. Roux, K. Uyhazi, A. Frost and P. D. Camilli, Nature, 2006, 441, 528531.
Page 13 of 15 Faraday Discussions
)D
UDG
D\
'LV
FX
VV
LRQ
V$
FF
HS
WHG
0D
QX
VF
ULS
W
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
4 
Ju
ly
 2
02
0.
 D
ow
nl
oa
de
d 
on
 8
/3
/2
02
0 
1:
17
:2
2 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
DOI: 10.1039/D0FD00042F
9 L. Christ, C. Raiborg, E. M. Wenzel, C. Campsteijn and H. Stenmark, Trends Biochem. Sci., 2017, 42, 
4256.
10 D. J. Thaller and C. P. Lusk, Biochemical Society Transactions, 2018, 46, 877889.
11 J. H. Hurley, EMBO J., 2015, 34, 23982407.
12 J. H. Hurley and P. I. Hanson, Nat Rev Mol Cell Biol, 2010, 11, 556566.
13 S. Maity, C. Caillat, N. Miguet, G. Sulbaran, G. Effantin, G. Schoehn, W. H. Roos and W. 
Weissenhorn, Science Advances, 2019, 5, eaau7198.
14 T. Wollert, C. Wunder, J. Lippincott-Schwartz and J. H. Hurley, Nature, 2009, 458, 172177.
15 A. Booth, C. J. Marklew, B. Ciani and P. A. Beales, iScience, 2019, 15, 173184.
16 C. J. Marklew, A. Booth, P. A. Beales and B. Ciani, Interface Focus, 2018, 8, 20180035.
17 J. H Hurley, Y. Tsujishita and M. Pearson, Current Opinion in Structural Biology, 2000, 10, 
737743.
18 I.-H. Lee, H. Kai, L.-A. Carlson, J. T. Groves and J. H. Hurley, PNAS, 2015, 112, 1589215897.
19 W. M. Henne, N. J. Buchkovich and S. D. Emr, Developmental Cell, 2011, 21, 7791.
20 A. L. Schuh and A. Audhya, Crit Rev Biochem Mol Biol, 2014, 49, 242261.
21 G. Bodon, R. Chassefeyre, K. Pernet-Gallay, N. Martinelli, G. Effantin, D. L. Hulsik, A. Belly, Y. 
Goldberg, C. Chatellard-Causse, B. Blot, G. Schoehn, W. Weissenhorn and R. Sadoul, J. Biol. Chem., 
2011, 286, 4027640286.
22 N. D. Franceschi, M. Alqabandi, N. Miguet, C. Caillat, S. Mangenot, W. Weissenhorn and P. 
Bassereau, J Cell Sci, , DOI:10.1242/jcs.217968.
23 T. Baumgart, A. T. Hammond, P. Sengupta, S. T. Hess, D. A. Holowka, B. A. Baird and W. W. 
Webb, PNAS, 2007, 104, 31653170.
24 N. Kahya, D. Scherfeld, K. Bacia, B. Poolman and P. Schwille, J. Biol. Chem., 2003, 278, 
2810928115.
25 S. L. Veatch and S. L. Keller, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 
2005, 1746, 172185.
26 S. L. Veatch and S. L. Keller, Phys. Rev. Lett., 2002, 89, 268101.
27 T. Baumgart, G. Hunt, E. R. Farkas, W. W. Webb and G. W. Feigenson, Biochim Biophys Acta, 
2007, 1768, 21822194.
28 A. S. Klymchenko and R. Kreder, Chemistry & Biology, 2014, 21, 97113.
29 Y. Avalos-Padilla, R. L. Knorr, R. Javier-Reyna, G. García-Rivera, R. Lipowsky, R. Dimova and E. 
Orozco, Front. Cell. Infect. Microbiol., , DOI:10.3389/fcimb.2018.00053.
30 S. L. Veatch and S. L. Keller, Biophysical Journal, 2003, 85, 30743083.
31 R. D. Usery, T. A. Enoki, S. P. Wickramasinghe, V. P. Nguyen, D. G. Ackerman, D. V. 
Greathouse, R. E. Koeppe, F. N. Barrera and G. W. Feigenson, Biophysical Journal, 2018, 114, 2152
2164.
32 M. A. Zhukovsky, A. Filograna, A. Luini, D. Corda and C. Valente, Front. Cell Dev. Biol., , 
DOI:10.3389/fcell.2019.00291.
33 N. J. Buchkovich, W. M. Henne, S. Tang and S. D. Emr, Dev. Cell, 2013, 27, 201214.
34 T. Baumgart, S. T. Hess and W. W. Webb, Nature, 2003, 425, 821824.
35 V. D. Gordon, M. Deserno, C. M. J. Andrew, S. U. Egelhaaf and W. C. K. Poon, EPL, 2008, 84, 
48003.
36 C. King, P. Sengupta, A. Y. Seo and J. Lippincott-Schwartz, PNAS, 2020, 117, 72257235.
37 E. Boura, V. Ivanov, L.-A. Carlson, K. Mizuuchi and J. H. Hurley, J. Biol. Chem., 2012, 287, 
2814428151.
38 R. Lipowsky and R. Dimova, J. Phys.: Condens. Matter, 2002, 15, S31S45.
39 B. FG1$ E. Boura, J. H. Hurley and G. Hummer, PLOS Computational Biology, 2012, 8, 
e1002736.
40 J. Liu, M. Kaksonen, D. G. Drubin and G. Oster, PNAS, 2006, 103, 1027710282.
41 W. Römer, L.-L. Pontani, B. Sorre, C. Rentero, L. Berland, V. Chambon, C. Lamaze, P. 
Bassereau, C. Sykes, K. Gaus and L. Johannes, Cell, 2010, 140, 540553.
Page 14 of 15Faraday Discussions
)D
UDG
D\
'LV
FX
VV
LRQ
V$
FF
HS
WHG
0D
QX
VF
ULS
W
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
4 
Ju
ly
 2
02
0.
 D
ow
nl
oa
de
d 
on
 8
/3
/2
02
0 
1:
17
:2
2 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
DOI: 10.1039/D0FD00042F
42 J. H. Hurley, E. Boura, L.-A. Carlson and B. Rózycki, Cell, 2010, 143, 875887.
43 T. Skotland, K. Sandvig and A. Llorente, Progress in Lipid Research, 2017, 66, 3041.
44 A. Llorente, T. Skotland, T. Sylvänne, D. Kauhanen, T. Róg, A. AJ! I. Vattulainen, K. 
Ekroos and K. Sandvig, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 
2013, 1831, 13021309.
45 K. Laulagnier, C. Motta, S. Hamdi, S. Roy, F. Fauvelle, J.-F. Pageaux, T. Kobayashi, J.-P. Salles, 
B. Perret, C. Bonnerot and M. Record, Biochem J, 2004, 380, 161171.
46 K. Sobo, J. Chevallier, R. G. Parton, J. Gruenberg and F. G. van der Goot, PLoS One, , 
DOI:10.1371/journal.pone.0000391.
47 J. H. Lorent, K. R. Levental, L. Ganesan, G. Rivera-Longsworth, E. Sezgin, M. Doktorova, E. 
Lyman and I. Levental, Nature Chemical Biology, 2020, 16, 644652.
48 M. Babst, D. J. Katzmann, E. J. Estepa-Sabal, T. Meerloo and S. D. Emr, Dev. Cell, 2002, 3, 
271282.
49 J. Bigay and B. Antonny, Developmental Cell, 2012, 23, 886895.
50 R. S. Gracià, N. Bezlyepkina, R. L. Knorr, R. Lipowsky and R. Dimova, Soft Matter, 2010, 6, 
14721482.
51 J. Lafaurie-Janvore, P. Maiuri, I. Wang, M. Pinot, J.-B. Manneville, T. Betz, M. Balland and M. 
Piel, Science, 2013, 339, 16251629.
52 A. J. Jimenez, P. Maiuri, J. Lafaurie-Janvore, S. Divoux, M. Piel and F. Perez, Science, 2014, 
343, 1247136.
53 Y.-N. Gong, C. Guy, H. Olauson, J. U. Becker, M. Yang, P. Fitzgerald, A. Linkermann and D. R. 
Green, Cell, 2017, 169, 286-300.e16.
54 T. Wollert and J. H. Hurley, Nature, 2010, 464, 864869.
Page 15 of 15 Faraday Discussions
)D
UDG
D\
'LV
FX
VV
LRQ
V$
FF
HS
WHG
0D
QX
VF
ULS
W
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
4 
Ju
ly
 2
02
0.
 D
ow
nl
oa
de
d 
on
 8
/3
/2
02
0 
1:
17
:2
2 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
DOI: 10.1039/D0FD00042F
